DDW exclusive: 2022 drug discovery challenges and opportunities

DDW exclusive: 2022 drug discovery challenges

Drug Discovery World spoke to key decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector, including Dan O’Connor, Molecular Devices Vice President Drug Discovery, who touches on how the company is driving a future where 3D biology is more widely adopted, bringing novel medicines to market sooner and improving health around the world.

Access full article: DDW exclusive: 2022 drug discovery challenges and opportunities